Mostrar el registro sencillo del ítem

dc.contributor.authorGonzález-Gascón Y Marín, Isabel
dc.contributor.authorHernández-Sanchez, María
dc.contributor.authorRodríguez-Vicente, Ana E
dc.contributor.authorPuiggros, Anna
dc.contributor.authorCollado, Rosa
dc.contributor.authorLuño, Elisa
dc.contributor.authorGonzález, Teresa
dc.contributor.authorRuiz-Xivillé, Neus
dc.contributor.authorOrtega, Margarita
dc.contributor.authorGimeno, Eva
dc.contributor.authorMuñoz, Carolina
dc.contributor.authorInfante, Maria Stefania
dc.contributor.authorDelgado, Julio
dc.contributor.authorVargas, María Teresa
dc.contributor.authorGonzález, Marcos
dc.contributor.authorBosch, Francesc
dc.contributor.authorEspinet, Blanca
dc.contributor.authorHernández Rivas, Jesús María 
dc.contributor.authorHernández, José Ángel
dc.contributor.authorGonzález-Gascón y Marín, Isabel
dc.date.accessioned2025-01-23T11:04:29Z
dc.date.available2025-01-23T11:04:29Z
dc.date.issued2018-03
dc.identifier.issn1042-8194
dc.identifier.urihttp://hdl.handle.net/10366/162359
dc.description.abstract[EN]We analyzed the features of chronic lymphocytic leukemia (CLL) with multiple abnormalities (MA) detected by FISH. A local database including 2095 CLL cases was used and 323 with MA (15.4%) were selected. MA was defined by the presence of two or more alterations (deletions of 13q14 (13q-), 11q22 (11q-), 17p13 (17p-) or trisomy 12 (+12)). The combination of 13q- with 11q- and 13q- with 17p-, accounted for 58.2% of the series, in contrast to 11q- with 17p- (3.7%). Patients carrying MA since diagnosis presented a short time to first therapy(TTFT) (27 months) and overall survival (OS) (76 months). The combinations including 17p- had a shorter OS (58 months) than the ones without 17p- (not reached, p = .002). Patients with a complex-FISH were the ones with worse OS (34 months). MA imply poor prognosis when they emerge at diagnosis, probably due to the high incidence of bad prognosis markers, which may be a reflection of a more complex karyotype.es_ES
dc.language.isoenges_ES
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectLeucemia linfocítica crónicaes_ES
dc.subjectanomalías múltipleses_ES
dc.subjectpronósticoes_ES
dc.subjecthibridación in situ fluorescentees_ES
dc.subject.meshPrognosis *
dc.subject.meshChromosome Aberrations *
dc.subject.meshAged *
dc.subject.meshChromosomes *
dc.subject.meshLeukemia *
dc.subject.meshAdult *
dc.subject.meshFollow-Up Studies *
dc.subject.meshHumans *
dc.subject.meshIn Situ Hybridization *
dc.subject.meshMiddle Aged *
dc.subject.meshSurvival Rate *
dc.subject.meshRetrospective Studies *
dc.titleCharacterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.es_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publishversionhttps://doi.org/10.1080/10428194.2017.1349901es_ES
dc.identifier.doi10.1080/10428194.2017.1349901
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.pmid28728469
dc.identifier.essn1029-2403
dc.journal.titleLeukemia & lymphomaes_ES
dc.volume.number59es_ES
dc.issue.number3es_ES
dc.page.initial633es_ES
dc.page.final642es_ES
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES
dc.subject.decspronóstico *
dc.subject.decsadulto *
dc.subject.decshibridación in situ *
dc.subject.decshumanos *
dc.subject.decsanciano *
dc.subject.decsaberraciones cromosómicas *
dc.subject.decsestudios de seguimiento *
dc.subject.decsmediana edad *
dc.subject.decsleucemia *
dc.subject.decsestudios retrospectivos *
dc.subject.decscromosomas *
dc.subject.decstasa de supervivencia *


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional